Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2010
11/23/2010US7838012 isolation of the fibrinogen binding protein gene from Staphylococcus aureus and use of the fibrinogen binding protein and antibodies generated against it for wound healing, blocking adherence to indwelling medical devices, immunization or diagnosis of infection
11/23/2010US7838011 a transdermal mixture of collagen, elastin, sphingoside, cerebroside and botulinum toxin
11/23/2010US7838010 inducing immunity against Streptococcus pyogenes by administering to an individual an effective amount of Group A streptococcal antigens
11/23/2010US7838009 treating a subject with a kidney obstructed by a naturally formed kidney stone or a subject with a pancreas obstructed by naturally formed pancreatic duct stone by direct injection of an effective amount of a solution or suspension of botulinum toxin into the obstructed kidney or obstructed pancreas
11/23/2010US7838008 Locally administering a botulinum neurotoxin to a cancer or to the vicinity of the afflicted atypical tissue
11/23/2010US7838007 Methods for treating mammary gland disorders
11/23/2010US7838006 Viral vaccine composition, process and methods of use
11/23/2010US7838005 Treatment of insulin resistance by administering an acid-sensing ion channel 3 inhibitor
11/23/2010US7838003 For diagnostic, prophylactic and therapeutic uses; vaccines
11/23/2010US7838002 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents
11/23/2010US7838001 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
11/23/2010US7838000 delivery of a polypeptide comprising at least a portion of the G domain of the laminin-5 alpha 3 chain that has been shown to bind alpha 6 beta 1 integrin receptors and alpha 6 beta 4 integrin receptors; breast cancer
11/23/2010US7837999 fusion polypeptide comprises an insulin-like growth factor 1 (IGF1) variant polypeptide component and a fusion component that is an Fc domain of human IgG; used where muscle atrophy or sarcopenia results from cachexia, immobilization, aging, chronic disease, or cancer
11/23/2010US7837998 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
11/23/2010US7837997 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/23/2010US7837996 treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention; exhibits immunological binding affinity for a hepatitis C virus (HCV) E1 antigen
11/23/2010US7837995 Anticancer agents; low dosage; side effect reduction
11/23/2010US7837994 Use of anti-IL-20 antibody for treating osteoporosis
11/23/2010US7837993 Methods and compositions for regeneration of aged skeletal muscle tissues
11/23/2010US7837980 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/23/2010CA2462085C Cytotoxic agents
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/23/2010CA2258125C T-cell epitope peptides
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2132421C Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/18/2010WO2010132872A1 Combination therapies and methods using anti-cd3 modulating agents and anti-tnf antagonists
11/18/2010WO2010132833A1 Streptococcus vaccine compositions and methods of using the same
11/18/2010WO2010132764A2 Live-attenuated compositions for bacterial infections
11/18/2010WO2010132758A2 Ospc-based diagnostic test for lyme disease
11/18/2010WO2010132742A1 Methods and compositions for modulating erbb2 activity
11/18/2010WO2010132697A2 Methods and compositions for treatment
11/18/2010WO2010132683A1 Methods and compositions for treating lupus
11/18/2010WO2010132659A2 Anti-human cd52 immunoglobulins
11/18/2010WO2010132622A2 Anticd20-cpg conjugates and methods of treating b cell malignancies
11/18/2010WO2010132561A2 New human rotavirus strains and vaccines
11/18/2010WO2010132389A2 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
11/18/2010WO2010132360A1 Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
11/18/2010WO2010132112A2 Immunogenic compositions against tuberculosis
11/18/2010WO2010132054A1 Compositions and methods for immunodominant antigens of mycobacterium tuberculosis
11/18/2010WO2010132047A1 Guanosine/gmp gels and uses thereof
11/18/2010WO2010131733A1 Anti-axl antibody
11/18/2010WO2010131704A1 Test agent for visceral obesity and use thereof
11/18/2010WO2010131590A1 Diagnostic agent and therapeutic agent for tumors
11/18/2010WO2010131235A1 Inhibitory antibody fragments to human tissue factor
11/18/2010WO2010131114A2 Carbohydrate binding module and use thereof
11/18/2010WO2010131009A2 Treatment of il-25 mediated diseases with tlr antagonists
11/18/2010WO2010130946A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
11/18/2010WO2010130899A1 Meningococcal vaccine based on lipooligosaccharide (los) and neisseria meningitidis protein
11/18/2010WO2010130898A2 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
11/18/2010WO2010130897A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
11/18/2010WO2010130896A2 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010WO2010130756A1 Immortalized avian cell lines and use thereof
11/18/2010WO2010130753A1 Method for orthopoxvirus production and purification
11/18/2010WO2010130751A1 Humanized axl antibodies
11/18/2010WO2010130683A1 Glycan antigen
11/18/2010WO2010130636A1 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
11/18/2010WO2010130374A1 Enhanced immune response in avian species
11/18/2010WO2010110931A3 Glycoconjugate vaccines
11/18/2010WO2010108182A3 Production of recombinant proteins in ciliates and uses thereof
11/18/2010WO2010106431A3 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof
11/18/2010WO2010102171A3 Secreted ap2 and methods of inhibiting same
11/18/2010WO2010100056A3 Antibodies against a proliferating inducing ligand (april)
11/18/2010WO2010080623A3 Anti-fxi antibodies and methods of use
11/18/2010WO2010079991A3 Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same
11/18/2010WO2010077422A3 Formulations of single domain antigen binding molecules
11/18/2010WO2010075423A3 Dendrimer based modular platforms
11/18/2010WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor
11/18/2010WO2010034670A3 Host cell kinases as targets for antiviral therapies against hcv infection
11/18/2010US20100292453 Lectin compositions and methods for modulating an immune response to an antigen
11/18/2010US20100292164 Dimerized peptide
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291212 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
11/18/2010US20100291193 Immunogenic compositions comprising progastrin and uses thereof
11/18/2010US20100291192 Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria
11/18/2010US20100291177 Prevention of staphylococcus biofilm formation
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291156 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
11/18/2010US20100291155 Allergy vaccine composition for mucosal administration
11/18/2010US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants
11/18/2010US20100291152 Chemically modified peptides with improved immunogenicity
11/18/2010US20100291151 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
11/18/2010US20100291150 Pseudomonas exotoxin a cd4+ t-cell epitopes
11/18/2010US20100291149 Attenuated listeria spp. and methods for using the same
11/18/2010US20100291148 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens
11/18/2010US20100291147 Recombinant rsv antigens
11/18/2010US20100291146 Method of eliciting an immune response against pandemic influenza virus
11/18/2010US20100291145 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
11/18/2010US20100291144 Novel vaccines against multiple subtypes of dengue virus
11/18/2010US20100291143 Inhibition of HIV and SHIV Replication with Antisense Interleukin-4
11/18/2010US20100291142 Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof
11/18/2010US20100291141 Truncated l1 protein of human papillomavirus type 11
11/18/2010US20100291140 Antibiotic resistance free listeria strains and methods for constructing and using same
11/18/2010US20100291139 Recombinant mva virus and the use thereof
11/18/2010US20100291138 Vaccine
11/18/2010US20100291137 Method for refolding neisserial nspa protein
11/18/2010US20100291136 Pharmaceutical Liquid Composition of Botulinum Toxin With Improved Stability
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
1 ... 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 ... 1823